Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017102
The University of Chicago
Search grants from The University of Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Virus-DNA-Virus hybrid vaccines for the prevention of Influenza
Development of SUPR peptides as PET Imaging Agents for Her2+ Breast Cancer
Amyloid PET in AD, FTLD &PPA: Diagnosis, Functional &Structural Correlations
Mechanisms of Persistence in Head Direction Cells
Alcohol and Endothelial Nitric Oxide Sythase
Recently added grants:
Functional analysis of autism risk genes during neural development using single cell seq
The Role of Neuronal Ensembles Supporting Auditory Fear Conditioning (Engrams) in the Amygdala in Memory Formation, Generalization and Extinction
Severe Maternal Morbidity: An Investigation of Racial-Ethnic Disparities, Social Disadvantage & Maternal Weight
Dynamic Cellular Interactions Associated with Inflammatory Monocyte Accumulation in the Neurovasculature with Social Stress
Community-based Intervention Effects on Older Adults' Physical Activity and Falls
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017102-005
Application #
6688651
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
The University of Chicago
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
Comments
Be the first to comment on this grant